Evaluating Tominersen Effect On Self-Reported Quality Of Life With High-Frequency Longitudinal, Digital EuroQoL 5-Dimensions 5-Level Survey In Generation HD1, A Phase III Trial Of Tominersen In Adult Individuals With Manifest Huntington's Disease